Industry Research Reports
Home > Reports > Service & Software > Global DNA Microinjection Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Global DNA Microinjection Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-21
Pages: 143 Pages
Report ld: 4929322
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
DNA Microinjection Services Market Size(US$)
CAGR 2025-2031
7.1%
Market Size,2031
USD 522
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 346 million
Market Forecast in 2031(Value)
US$ 522 million
CAGR
7.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global DNA Microinjection Services market is projected to grow from US$ 340 million in 2024 to US$ 522 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
DNA microinjection is a high-precision gene transfer technology primarily used to directly inject exogenous DNA into the fertilized egg or cell nucleus of a mammal to achieve gene editing or the creation of transgenic animals. This technology relies on a micromanipulation platform, using a microinjection needle to precisely inject a DNA solution into the pronucleus of a target cell or embryo under a microscope. This process is commonly used in areas such as studying gene function, constructing disease models, drug screening, and biological breeding. The advantages of microinjection lie in its high efficiency and wide applicability; virtually any DNA fragment can be introduced into a variety of cell types or embryos. Despite its complex operation and expensive equipment, it remains one of the most direct and commonly used transgenic methods, particularly in the construction of animal models such as mice, pigs, and cattle.
From a downstream perspective, Biomedicine accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
DNA Microinjection Services leading manufacturers including Charles River, PolyGene, Taconic Biosciences, GenOway, Applied StemCell, JAX Mice, Biomodels, ModelOrg, Cyagen Biosciences, Biocytogen, etc., dominate supply; the top five capture approximately % of global revenue, with Charles River leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global DNA Microinjection Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Charles River
- PolyGene
- Taconic Biosciences
- GenOway
- Applied StemCell
- JAX Mice
- Biomodels
- ModelOrg
- Cyagen Biosciences
- Biocytogen
- GemPharmatech
- Nanjing Aibei Biotechnology
- Nanjing Senbega Biotechnology
- Hangzhou Baiti Biotechnology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pronuclear Injection
- Cytoplasmic Injection
- Blastocyst Injection
- Others
Segment by Application
- Biomedicine
- Agriculture & Animal Husbandry
- Others
CHAPTER OUTLINE
Chapter 1: Defines the DNA Microinjection Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to DNA Microinjection Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global DNA Microinjection Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pronuclear Injection
1.2.3 Cytoplasmic Injection
1.2.4 Blastocyst Injection
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global DNA Microinjection Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomedicine
1.3.3 Agriculture & Animal Husbandry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global DNA Microinjection Services Revenue Estimates and Forecasts 2020-2031
2.2 Global DNA Microinjection Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global DNA Microinjection Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global DNA Microinjection Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Pronuclear Injection Market Size by Players
3.3.2 Cytoplasmic Injection Market Size by Players
3.3.3 Blastocyst Injection Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global DNA Microinjection Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global DNA Microinjection Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global DNA Microinjection Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America DNA Microinjection Services Market Size by Type (2020-2031)
6.4 North America DNA Microinjection Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America DNA Microinjection Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe DNA Microinjection Services Market Size by Type (2020-2031)
7.4 Europe DNA Microinjection Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe DNA Microinjection Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific DNA Microinjection Services Market Size by Type (2020-2031)
8.4 Asia-Pacific DNA Microinjection Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific DNA Microinjection Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America DNA Microinjection Services Market Size by Type (2020-2031)
9.4 Central and South America DNA Microinjection Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America DNA Microinjection Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa DNA Microinjection Services Market Size by Type (2020-2031)
10.4 Middle East and Africa DNA Microinjection Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa DNA Microinjection Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River DNA Microinjection Services Product Features and Attributes
11.1.4 Charles River DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.1.5 Charles River DNA Microinjection Services Revenue by Product in 2024
11.1.6 Charles River DNA Microinjection Services Revenue by Application in 2024
11.1.7 Charles River DNA Microinjection Services Revenue by Geographic Area in 2024
11.1.8 Charles River DNA Microinjection Services SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 PolyGene
11.2.1 PolyGene Corporation Information
11.2.2 PolyGene Business Overview
11.2.3 PolyGene DNA Microinjection Services Product Features and Attributes
11.2.4 PolyGene DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.2.5 PolyGene DNA Microinjection Services Revenue by Product in 2024
11.2.6 PolyGene DNA Microinjection Services Revenue by Application in 2024
11.2.7 PolyGene DNA Microinjection Services Revenue by Geographic Area in 2024
11.2.8 PolyGene DNA Microinjection Services SWOT Analysis
11.2.9 PolyGene Recent Developments
11.3 Taconic Biosciences
11.3.1 Taconic Biosciences Corporation Information
11.3.2 Taconic Biosciences Business Overview
11.3.3 Taconic Biosciences DNA Microinjection Services Product Features and Attributes
11.3.4 Taconic Biosciences DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.3.5 Taconic Biosciences DNA Microinjection Services Revenue by Product in 2024
11.3.6 Taconic Biosciences DNA Microinjection Services Revenue by Application in 2024
11.3.7 Taconic Biosciences DNA Microinjection Services Revenue by Geographic Area in 2024
11.3.8 Taconic Biosciences DNA Microinjection Services SWOT Analysis
11.3.9 Taconic Biosciences Recent Developments
11.4 GenOway
11.4.1 GenOway Corporation Information
11.4.2 GenOway Business Overview
11.4.3 GenOway DNA Microinjection Services Product Features and Attributes
11.4.4 GenOway DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.4.5 GenOway DNA Microinjection Services Revenue by Product in 2024
11.4.6 GenOway DNA Microinjection Services Revenue by Application in 2024
11.4.7 GenOway DNA Microinjection Services Revenue by Geographic Area in 2024
11.4.8 GenOway DNA Microinjection Services SWOT Analysis
11.4.9 GenOway Recent Developments
11.5 Applied StemCell
11.5.1 Applied StemCell Corporation Information
11.5.2 Applied StemCell Business Overview
11.5.3 Applied StemCell DNA Microinjection Services Product Features and Attributes
11.5.4 Applied StemCell DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.5.5 Applied StemCell DNA Microinjection Services Revenue by Product in 2024
11.5.6 Applied StemCell DNA Microinjection Services Revenue by Application in 2024
11.5.7 Applied StemCell DNA Microinjection Services Revenue by Geographic Area in 2024
11.5.8 Applied StemCell DNA Microinjection Services SWOT Analysis
11.5.9 Applied StemCell Recent Developments
11.6 JAX Mice
11.6.1 JAX Mice Corporation Information
11.6.2 JAX Mice Business Overview
11.6.3 JAX Mice DNA Microinjection Services Product Features and Attributes
11.6.4 JAX Mice DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.6.5 JAX Mice Recent Developments
11.7 Biomodels
11.7.1 Biomodels Corporation Information
11.7.2 Biomodels Business Overview
11.7.3 Biomodels DNA Microinjection Services Product Features and Attributes
11.7.4 Biomodels DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.7.5 Biomodels Recent Developments
11.8 ModelOrg
11.8.1 ModelOrg Corporation Information
11.8.2 ModelOrg Business Overview
11.8.3 ModelOrg DNA Microinjection Services Product Features and Attributes
11.8.4 ModelOrg DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.8.5 ModelOrg Recent Developments
11.9 Cyagen Biosciences
11.9.1 Cyagen Biosciences Corporation Information
11.9.2 Cyagen Biosciences Business Overview
11.9.3 Cyagen Biosciences DNA Microinjection Services Product Features and Attributes
11.9.4 Cyagen Biosciences DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.9.5 Cyagen Biosciences Recent Developments
11.10 Biocytogen
11.10.1 Biocytogen Corporation Information
11.10.2 Biocytogen Business Overview
11.10.3 Biocytogen DNA Microinjection Services Product Features and Attributes
11.10.4 Biocytogen DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 GemPharmatech
11.11.1 GemPharmatech Corporation Information
11.11.2 GemPharmatech Business Overview
11.11.3 GemPharmatech DNA Microinjection Services Product Features and Attributes
11.11.4 GemPharmatech DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.11.5 GemPharmatech Recent Developments
11.12 Nanjing Aibei Biotechnology
11.12.1 Nanjing Aibei Biotechnology Corporation Information
11.12.2 Nanjing Aibei Biotechnology Business Overview
11.12.3 Nanjing Aibei Biotechnology DNA Microinjection Services Product Features and Attributes
11.12.4 Nanjing Aibei Biotechnology DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.12.5 Nanjing Aibei Biotechnology Recent Developments
11.13 Nanjing Senbega Biotechnology
11.13.1 Nanjing Senbega Biotechnology Corporation Information
11.13.2 Nanjing Senbega Biotechnology Business Overview
11.13.3 Nanjing Senbega Biotechnology DNA Microinjection Services Product Features and Attributes
11.13.4 Nanjing Senbega Biotechnology DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.13.5 Nanjing Senbega Biotechnology Recent Developments
11.14 Hangzhou Baiti Biotechnology
11.14.1 Hangzhou Baiti Biotechnology Corporation Information
11.14.2 Hangzhou Baiti Biotechnology Business Overview
11.14.3 Hangzhou Baiti Biotechnology DNA Microinjection Services Product Features and Attributes
11.14.4 Hangzhou Baiti Biotechnology DNA Microinjection Services Revenue and Gross Margin (2020-2025)
11.14.5 Hangzhou Baiti Biotechnology Recent Developments
12 DNA Microinjection ServicesIndustry Chain Analysis
12.1 DNA Microinjection Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 DNA Microinjection Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global DNA Microinjection Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global DNA Microinjection Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global DNA Microinjection Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global DNA Microinjection Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global DNA Microinjection Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global DNA Microinjection Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global DNA Microinjection Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global DNA Microinjection Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global DNA Microinjection Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Microinjection Services as of 2024)
Table 11. Global DNA Microinjection Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global DNA Microinjection Services Companies Headquarters
Table 13. Global DNA Microinjection Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global DNA Microinjection Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global DNA Microinjection Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global DNA Microinjection Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global DNA Microinjection Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. DNA Microinjection Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America DNA Microinjection Services Growth Accelerators and Market Barriers
Table 25. North America DNA Microinjection Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe DNA Microinjection Services Growth Accelerators and Market Barriers
Table 27. Europe DNA Microinjection Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific DNA Microinjection Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific DNA Microinjection Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America DNA Microinjection Services Investment Opportunities and Key Challenges
Table 31. Central and South America DNA Microinjection Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa DNA Microinjection Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa DNA Microinjection Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Charles River Corporation Information
Table 35. Charles River Description and Major Businesses
Table 36. Charles River Product Features and Attributes
Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Charles River Revenue Proportion by Product in 2024
Table 39. Charles River Revenue Proportion by Application in 2024
Table 40. Charles River Revenue Proportion by Geographic Area in 2024
Table 41. Charles River DNA Microinjection Services SWOT Analysis
Table 42. Charles River Recent Developments
Table 43. PolyGene Corporation Information
Table 44. PolyGene Description and Major Businesses
Table 45. PolyGene Product Features and Attributes
Table 46. PolyGene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. PolyGene Revenue Proportion by Product in 2024
Table 48. PolyGene Revenue Proportion by Application in 2024
Table 49. PolyGene Revenue Proportion by Geographic Area in 2024
Table 50. PolyGene DNA Microinjection Services SWOT Analysis
Table 51. PolyGene Recent Developments
Table 52. Taconic Biosciences Corporation Information
Table 53. Taconic Biosciences Description and Major Businesses
Table 54. Taconic Biosciences Product Features and Attributes
Table 55. Taconic Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Taconic Biosciences Revenue Proportion by Product in 2024
Table 57. Taconic Biosciences Revenue Proportion by Application in 2024
Table 58. Taconic Biosciences Revenue Proportion by Geographic Area in 2024
Table 59. Taconic Biosciences DNA Microinjection Services SWOT Analysis
Table 60. Taconic Biosciences Recent Developments
Table 61. GenOway Corporation Information
Table 62. GenOway Description and Major Businesses
Table 63. GenOway Product Features and Attributes
Table 64. GenOway Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. GenOway Revenue Proportion by Product in 2024
Table 66. GenOway Revenue Proportion by Application in 2024
Table 67. GenOway Revenue Proportion by Geographic Area in 2024
Table 68. GenOway DNA Microinjection Services SWOT Analysis
Table 69. GenOway Recent Developments
Table 70. Applied StemCell Corporation Information
Table 71. Applied StemCell Description and Major Businesses
Table 72. Applied StemCell Product Features and Attributes
Table 73. Applied StemCell Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Applied StemCell Revenue Proportion by Product in 2024
Table 75. Applied StemCell Revenue Proportion by Application in 2024
Table 76. Applied StemCell Revenue Proportion by Geographic Area in 2024
Table 77. Applied StemCell DNA Microinjection Services SWOT Analysis
Table 78. Applied StemCell Recent Developments
Table 79. JAX Mice Corporation Information
Table 80. JAX Mice Description and Major Businesses
Table 81. JAX Mice Product Features and Attributes
Table 82. JAX Mice Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. JAX Mice Recent Developments
Table 84. Biomodels Corporation Information
Table 85. Biomodels Description and Major Businesses
Table 86. Biomodels Product Features and Attributes
Table 87. Biomodels Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Biomodels Recent Developments
Table 89. ModelOrg Corporation Information
Table 90. ModelOrg Description and Major Businesses
Table 91. ModelOrg Product Features and Attributes
Table 92. ModelOrg Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. ModelOrg Recent Developments
Table 94. Cyagen Biosciences Corporation Information
Table 95. Cyagen Biosciences Description and Major Businesses
Table 96. Cyagen Biosciences Product Features and Attributes
Table 97. Cyagen Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Cyagen Biosciences Recent Developments
Table 99. Biocytogen Corporation Information
Table 100. Biocytogen Description and Major Businesses
Table 101. Biocytogen Product Features and Attributes
Table 102. Biocytogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Biocytogen Recent Developments
Table 104. GemPharmatech Corporation Information
Table 105. GemPharmatech Description and Major Businesses
Table 106. GemPharmatech Product Features and Attributes
Table 107. GemPharmatech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. GemPharmatech Recent Developments
Table 109. Nanjing Aibei Biotechnology Corporation Information
Table 110. Nanjing Aibei Biotechnology Description and Major Businesses
Table 111. Nanjing Aibei Biotechnology Product Features and Attributes
Table 112. Nanjing Aibei Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Nanjing Aibei Biotechnology Recent Developments
Table 114. Nanjing Senbega Biotechnology Corporation Information
Table 115. Nanjing Senbega Biotechnology Description and Major Businesses
Table 116. Nanjing Senbega Biotechnology Product Features and Attributes
Table 117. Nanjing Senbega Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Nanjing Senbega Biotechnology Recent Developments
Table 119. Hangzhou Baiti Biotechnology Corporation Information
Table 120. Hangzhou Baiti Biotechnology Description and Major Businesses
Table 121. Hangzhou Baiti Biotechnology Product Features and Attributes
Table 122. Hangzhou Baiti Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Hangzhou Baiti Biotechnology Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. DNA Microinjection Services Product Picture
Figure 2. Global DNA Microinjection Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pronuclear Injection Product Picture
Figure 4. Cytoplasmic Injection Product Picture
Figure 5. Blastocyst Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global DNA Microinjection Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Biomedicine
Figure 9. Agriculture & Animal Husbandry
Figure 10. Others
Figure 11. DNA Microinjection Services Report Years Considered
Figure 12. Global DNA Microinjection Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 14. Global DNA Microinjection Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global DNA Microinjection Services Revenue Market Share by Region (2020-2031)
Figure 16. Global DNA Microinjection Services Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Pronuclear Injection Revenue Market Share by Player in 2024
Figure 19. Cytoplasmic Injection Revenue Market Share by Player in 2024
Figure 20. Blastocyst Injection Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global DNA Microinjection Services Revenue Market Share by Type (2020-2031)
Figure 23. Global DNA Microinjection Services Revenue Market Share by Application (2020-2031)
Figure 24. North America DNA Microinjection Services Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players DNA Microinjection Services Revenue (US$ Million) in 2024
Figure 26. North America DNA Microinjection Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America DNA Microinjection Services Revenue (US$ Million) by Application (2020-2031)
Figure 28. US DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 29. Canada DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 31. Europe DNA Microinjection Services Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players DNA Microinjection Services Revenue (US$ Million) in 2024
Figure 33. Europe DNA Microinjection Services Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe DNA Microinjection Services Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 36. France DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 38. Italy DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 39. Russia DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific DNA Microinjection Services Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players DNA Microinjection Services Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific DNA Microinjection Services Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific DNA Microinjection Services Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 45. Japan DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 47. Australia DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 48. India DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore DNA Microinjection Services Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America DNA Microinjection Services Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players DNA Microinjection Services Revenue (US$ Million) in 2024
Figure 56. Central and South America DNA Microinjection Services Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America DNA Microinjection Services Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil DNA Microinjection Services Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina DNA Microinjection Services Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa DNA Microinjection Services Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players DNA Microinjection Services Revenue (US$ Million) in 2024
Figure 62. South America DNA Microinjection Services Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa DNA Microinjection Services Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries DNA Microinjection Services Revenue (2020-2025) & (US$ Million)
Figure 65. Israel DNA Microinjection Services Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt DNA Microinjection Services Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa DNA Microinjection Services Revenue (2020-2025) & (US$ Million)
Figure 68. DNA Microinjection Services Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global DNA Microinjection Services market size from 2025 to 2031?
The annual compound growth rate of the global DNA Microinjection Services market is 7.1% 2025 to 2031.
What was the global market size of DNA Microinjection Services in 2025?
Which region is expected to have the highest market share?
What was the global market size of DNA Microinjection Services in 2031?
Which companies rank high in the global DNA Microinjection Services market?
Related Reports
Global DNA Microinjection Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global DNA Microinjection Services market is projected to grow from US$ 346 million in 2025 to US$ 556 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 132
USD 4900.00
(Single User License)
Global DNA Microinjection Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global DNA Microinjection Services market size was US$ 346 million in 2025 and is forecast to reach a readjusted size of US$ 556 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 94
USD 4250.00
(Single User License)
Global DNA Microinjection Services Market Research Report 2026
The global DNA Microinjection Services market was valued at US$ 346 million in 2025 and is anticipated to reach US$ 556 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 118
USD 2900.00
(Single User License)
DNA Microinjection Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for DNA Microinjection Services was estimated to be worth US$ 346 million in 2025 and is projected to reach US$ 556 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 116
USD 3950.00
(Single User License)
Global DNA Microinjection Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global DNA Microinjection Services market size was US$ 340 million in 2024 and is forecast to a readjusted size of US$ 522 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-08-22
Pages: 94
USD 4250.00
(Single User License)
DNA Microinjection Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for DNA Microinjection Services was estimated to be worth US$ 340 million in 2024 and is forecast to a readjusted size of US$ 522 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-08-22
Pages: 102
USD 3950.00
(Single User License)
Global DNA Microinjection Services Market Research Report 2025
The global market for DNA Microinjection Services was valued at US$ 340 million in the year 2024 and is projected to reach a revised size of US$ 522 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-08-22
Pages: 85
USD 2900.00
(Single User License)
Global DNA Microinjection Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global DNA Microinjection Services market is projected to grow from US$ 346 million in 2025 to US$ 556 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 132
USD 4900.00 (Single User License)Global DNA Microinjection Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global DNA Microinjection Services market size was US$ 346 million in 2025 and is forecast to reach a readjusted size of US$ 556 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 94
USD 4250.00 (Single User License)Global DNA Microinjection Services Market Research Report 2026
The global DNA Microinjection Services market was valued at US$ 346 million in 2025 and is anticipated to reach US$ 556 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-12
Pages: 118
USD 2900.00 (Single User License)DNA Microinjection Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for DNA Microinjection Services was estimated to be worth US$ 346 million in 2025 and is projected to reach US$ 556 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-09
Pages: 116
USD 3950.00 (Single User License)Global DNA Microinjection Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global DNA Microinjection Services market size was US$ 340 million in 2024 and is forecast to a readjusted size of US$ 522 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-08-22
Pages: 94
USD 4250.00 (Single User License)DNA Microinjection Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for DNA Microinjection Services was estimated to be worth US$ 340 million in 2024 and is forecast to a readjusted size of US$ 522 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-08-22
Pages: 102
USD 3950.00 (Single User License)Global DNA Microinjection Services Market Research Report 2025
The global market for DNA Microinjection Services was valued at US$ 340 million in the year 2024 and is projected to reach a revised size of US$ 522 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-08-22
Pages: 85
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now